Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.

Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.

Item
http://www.wikidata.org/entity/Q36293897
Small molecule compounds alleviate anisomycin-induced oxidative stress injury in SH-SY5Y cells via downregulation of p66shc and Aβ1-42 expression.New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats.HDL and microRNA therapeutics in cardiovascular disease.MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease.miRNAs in non-alcoholic fatty liver disease.The Hepatoprotective and MicroRNAs Downregulatory Effects of Crocin Following Hepatic Ischemia-Reperfusion Injury in Rats.Emerging roles of SIRT1 in fatty liver diseases.Carnosic acid prevents dextran sulfate sodium-induced acute colitis associated with the regulation of the Keap1/Nrf2 pathway.circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis.Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs.Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.Carnosic Acid Alleviates BDL-Induced Liver Fibrosis through miR-29b-3p-Mediated Inhibition of the High-Mobility Group Box 1/Toll-Like Receptor 4 Signaling Pathway in Rats.Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver.Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
P2860

Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.

Item
http://www.wikidata.org/entity/Q36293897
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Activation of the SIRT1/p66shc ...... alcoholic fatty liver disease.
@ast
Activation of the SIRT1/p66shc ...... alcoholic fatty liver disease.
@en
type
label
Activation of the SIRT1/p66shc ...... alcoholic fatty liver disease.
@ast
Activation of the SIRT1/p66shc ...... alcoholic fatty liver disease.
@en
prefLabel
Activation of the SIRT1/p66shc ...... alcoholic fatty liver disease.
@ast
Activation of the SIRT1/p66shc ...... alcoholic fatty liver disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Activation of the SIRT1/p66shc ...... nalcoholic fatty liver disease
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P932